Jasper Therapeutics, Inc. (JSPR) DCF Valuation

Jasper Therapeutics, Inc. (JSPR) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Jasper Therapeutics, Inc. (JSPR) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Jasper Therapeutics, Inc.'s (JSPR) financial prospects like an expert! This (JSPR) DCF Calculator is equipped with pre-filled financial data and allows you the flexibility to modify revenue growth, WACC, margins, and other essential assumptions to match your predictions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -.3 -31.9 -31.2 -38.2 -65.0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 4.7 .0 .6 1.3 1.1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -5.0 -32.0 -31.7 -39.5 -66.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 27.2 19.8 84.7 38.3 86.9 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .6 .0 .0 .3
Account Receivables, % 100 100 100 100 100
Inventories .0 .1 -.5 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .6 1.4 3.9 1.8 4.1 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 -2.4 -.6 -.3 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 2.46 2.46 2.46 2.46 2.46 2.46 2.46 2.46 2.46 2.46
EBITAT -5.0 -32.0 -24.8 -25.4 -64.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .3 -31.8 -23.0 -27.3 -61.5 -3.9 .0 .0 .0 .0
WACC, % 14.71 14.71 14.69 14.69 14.7 14.7 14.7 14.7 14.7 14.7
PV UFCF
SUM PV UFCF -3.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -3
Net Debt -84
Equity Value 81
Diluted Shares Outstanding, MM 10
Equity Value Per Share 7.73

What You Will Get

  • Pre-Filled Financial Model: Jasper Therapeutics’ actual data allows for accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, margins, WACC, and other vital drivers as needed.
  • Instant Calculations: Automatic updates provide real-time results as you adjust inputs.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for adaptability, enabling repeated application for in-depth forecasts.

Key Features

  • 🔍 Real-Life JSPR Financials: Pre-filled historical and projected data for Jasper Therapeutics, Inc. (JSPR).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Jasper’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Jasper’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Jasper Therapeutics data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Jasper Therapeutics’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Jasper Therapeutics, Inc. (JSPR)?

  • Accurate Data: Real Jasper Therapeutics financials provide dependable valuation outcomes.
  • Customizable: Modify essential parameters like growth projections, WACC, and tax rates to fit your estimates.
  • Time-Saving: Pre-configured calculations remove the hassle of starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotechnology sector.
  • User-Friendly: Intuitive design and clear instructions ensure accessibility for all users.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Jasper Therapeutics stock (JSPR).
  • Financial Analysts: Enhance valuation processes with accessible and comprehensive financial models.
  • Consultants: Provide clients with expert valuation insights quickly and with precision.
  • Business Owners: Gain insights into how biotech companies like Jasper Therapeutics are valued to inform your own business strategy.
  • Finance Students: Master valuation techniques using real-world data and industry scenarios.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Jasper Therapeutics historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Jasper Therapeutics, Inc. (JSPR).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.